Stille Signs Exclusive Distribution Agreement for Surgical Instruments in US

Report this content

Stille AB (publ) announces the appointment of Synovis Micro Companies Alliance, Inc,. as its exclusive distributor of surgical instruments in the United States.

With over 20 years of experience in the market, Synovis Micro Companies Alliance, Inc, a Baxter-owned company, has successfully targeted surgical disciplines that require the finest surgical instrumentation, including the microsurgical, plastics and cardiovascular disciplines. As of January 1st, 2022, Synovis has been appointed the exclusive distributor of Stille’s surgical instruments in the United States.

“This is a major step in the process of realizing the cross-sales synergies achieved through the acquisition of S&T and the continued growth objectives of our Surgical Instruments business unit. The acquisition of S&T allowed us to unify the surgical instrument industry’s top high-quality manufacturers in the premium segment, while also allowing us to unify our sales efforts into a single sales channel that is dedicated to our product portfolio and is well-positioned to drive growth in our strategically important surgical disciplines.”, says Markus Spingler., Business Unit Manager for Surgical Instruments at Stille.

Synovis has been a distributor of STILLE-instruments in the United States for over 6 years, while also having had the exclusive distribution rights for the microsurgical instruments of the recently acquired S&T, for almost 15 years.

“We have had a long and successful partnership with Synovis. They have been a key partner for Stille, penetrating the US-market with our premium instruments in the strategically important plastics and microsurgery segments, while at the same time driving consistent growth and account penetration with our S&T microsurgical instruments. Combining Stille’s unique product offering of surgical instruments with an exclusive distributor that has a strong presence in key strategic surgical disciplines will strengthen Stille’s overall market position in the United States, while bringing significant value to our business. We are proud to partner with, and to be represented by, Synovis MCA”, says Brian Anderson, General Manager for Stille’s US-based company, Stille Surgical, Inc.

“We are very excited about gaining the exclusive right to Stille’s product portfolio in the US. Our growing partnership allows us to continue helping our physicians and hospitals to provide the best possible outcomes in complicated procedures across multiple clinical disciplines.”, says Michael K. Campbell, President, Synovis Micro Companies Alliance, Inc.

This exclusive distribution agreement includes all products of Stille’s Surgical Instruments business unit.

Torshälla, February 15th, 2022.
 

For more information, please contact:

Hanna Ernestam Wilkman
CEO
+46 (0)72 402 10 88 | hanna.e.wilkman@stille.se

STILLE AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures, the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality.

The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser. Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information about Stille visit www.stille.se.